Asset Details
Do you wish to reserve the book?
Targeted pathophysiological treatment of ischemic stroke using nanoparticle-based drug delivery system
Hey, we have placed the reservation for you!
By the way, why not check out events that you can attend while you pick your title.
Oops! Something went wrong.
Looks like we were not able to place the reservation. Kindly try again later.
Are you sure you want to remove the book from the shelf?
Targeted pathophysiological treatment of ischemic stroke using nanoparticle-based drug delivery system
Do you wish to request the book?
Targeted pathophysiological treatment of ischemic stroke using nanoparticle-based drug delivery system
Please be aware that the book you have requested cannot be checked out. If you would like to checkout this book, you can reserve another copy
We have requested the book for you!
Your request is successful and it will be processed during the Library working hours. Please check the status of your request in My Requests.
Oops! Something went wrong.
Looks like we were not able to place your request. Kindly try again later.
Journal Article
Targeted pathophysiological treatment of ischemic stroke using nanoparticle-based drug delivery system
2024
Overview
Ischemic stroke poses significant challenges in terms of mortality and disability rates globally. A key obstacle to the successful treatment of ischemic stroke lies in the limited efficacy of administering therapeutic agents. Leveraging the unique properties of nanoparticles for brain targeting and crossing the blood–brain barrier, researchers have engineered diverse nanoparticle-based drug delivery systems to improve the therapeutic outcomes of ischemic stroke. This review provides a concise overview of the pathophysiological mechanisms implicated in ischemic stroke, encompassing oxidative stress, glutamate excitotoxicity, neuroinflammation, and cell death, to elucidate potential targets for nanoparticle-based drug delivery systems. Furthermore, the review outlines the classification of nanoparticle-based drug delivery systems according to these distinct physiological processes. This categorization aids in identifying the attributes and commonalities of nanoparticles that target specific pathophysiological pathways in ischemic stroke, thereby facilitating the advancement of nanomedicine development. The review discusses the potential benefits and existing challenges associated with employing nanoparticles in the treatment of ischemic stroke, offering new perspectives on designing efficacious nanoparticles to enhance ischemic stroke treatment outcomes.
Graphical Abstract
Publisher
BioMed Central,BioMed Central Ltd,BMC
Subject
/ Blood-Brain Barrier - metabolism
/ Brain Ischemia - drug therapy
/ Chemistry and Materials Science
/ Drug Delivery Systems - methods
/ Drugs
/ Humans
/ Ischemic Stroke - drug therapy
/ Methods
/ Nanoparticle Drug Delivery System - chemistry
/ Neuroprotective Agents - chemistry
/ Neuroprotective Agents - therapeutic use
/ Oxidative Stress - drug effects
/ Review
/ Vehicles
